期刊文献+

移植物体外净化白血病细胞模型的建立

Establishment of Models for Purging Leukemic Cells from the Grafts In Vitro
下载PDF
导出
摘要 本实验采用荧光素Calcein AM标记白血病细胞后分别接种入细胞株或骨髓细胞中以建立 3个白血病移植物细胞模型 ,采用免疫磁珠法对细胞模型进行选择 ,并用流式细胞术 (FCM)评价移植物模型中白血病细胞的净化效果。结果表明 :所建立的移植物细胞模型既可以用荧光显微镜分析 ,又可以用FCM进行精确评价。模型Ⅱ经免疫磁珠法体外净化后髓系白血病KG1a细胞的清除率为 (0 98± 0 0 9)log,模型Ⅲ中淋巴系白血病NALM 6细胞的清除率为 (1 82± 0 51 )log。结论 :建立的模型直观、稳定、重复性好 。 Using a fluorochrome Calcein AM, leukemia cells were labeled and seeded into cell lines or bone marrow cells to establish three cell models of grafts with leukemia. These cell models were engaged with CD34 immunomagnetic beads and the purging efficacy was evaluated using both fluorescence microscopy and flow cytometry. The results showed that the cell models established in this study could be evaluated successfully not only with fluorescence microscopy but also flow cytometry. After CD34 positive selection, KG1a cells were removed by (0 98±0 09)log in model Ⅱ and NALM 6 cells were rewosed by (1 82±0 51)log in model Ⅲ, respectively. It is concluded that the models established in this study are stable and direct with an excellent reproducibility and an accuracy which can be used to evaluate purging efficacy of leukemia cells in model graft using immunomagnetic selection and the experimental studies on tumorcidal effect in vitro.
出处 《中国实验血液学杂志》 CAS CSCD 2002年第5期433-437,共5页 Journal of Experimental Hematology
基金 浙江省自然科学基金 (编号 3984 2 7) 卫生部科学基金(编号 98 1 332)资助项目
关键词 白血病 免疫磁珠选择法 移植物净化模型 荧光素 Calcein—AM 流式细胞术 Leukemia immunomagnetic bead selection graft purging model
  • 相关文献

参考文献9

  • 1Deisseroth AB, Zu Z, Claxton D, et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplantation in CML. Blood, 1994; 83:3068- 3076
  • 2Berenson RJ, Bensinger WI, Hill RS, et al. Engraftment after infusion of CD34 + marrow cells in patients with breast cancer or neuroblastoma. Blood, 1991; 77:1717- 1722
  • 3Ross AA, Cooper BW, Lazarus HM, et al. Detection and viability of tumor cells in peripheral blood stem cells collections from breast cancer patients using immunocytochemical and clonogenic assay tech niques. Blood, 1993; 82:2605- 2610
  • 4To LB, Haylock DN, Simmons PJ, et al. The biology and clinical uses of blood stem cells. Blood, 1997; 89:2233- 2258
  • 5Diverio D, Rossi V, Awisati G, et al. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter ‘AIDA' trial. Blood, 1998; 92:784-789
  • 6Paulus U, Dreger P, Viehmann K, et al. Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems. Stem Cells, 1997;15: 297 - 304
  • 7Schiller G, Vescio R, Fregtes C, et al. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood, 1995; 86:390 -397
  • 8Roots-Weiss A, Papadimitriou C, Serve H, et al. The efficiency of tumor cell purging using immunomagnetic CD34 + cell separation systems. Bone Marrow Transplant, 1997; 19:1239- 1246
  • 9Mapara MY, Korner IJ, Hildebrandt M, et al. Monitoring of tumor cells purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients:comparision of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood, 1997; 89: 337 - 344

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部